Nanomedicine Based Drug Delivery Systems Recent Developments and Future Prospects

• Kolejni autorzy: Shakeel, Faiyaz (Redaktor)
• Format: Elektroniczne Rozdział
• Język: angielski
• Wydane: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Hasła przedmiotowe: Research & information: general; Chemistry; bioflavonoid; droplet size; hepatoprotective effects; luteolin; SNEDDS; cancer; smart nanocarriers; drug targeting; nanoparticles; stimulus for drug release; bioavailability; ciprofloxacin; lipid-based colloidal carriers; ocular delivery; turmeric rhizome extract; turmeric oil; curcumin; HepG2; anticancer; quality by design; quality planning; initial risk assessment; critical factors; thermosensitive liposomes; thin-film hydration method; dental diseases; essential oils; herb; natural products; nanotechnology; regulations; tedizolid-phosphate; chitosan; antibacterial; eye-irritation transcorneal-permeation; drug delivery; contraception; levonorgestrel; liposomes; microneedle; sustained-release; apremilast; psoriatic arthritis; pharmacokinetics studies; solubility; dissolution; oral bioavailability; functionalized fullerenes; fullerenols; antibiotics; gentamicin; antibacterial properties; cytotoxicity; skin fibroblasts; nanomedicine; tedizolid; antimicrobial; nanocrystals; eyeirritation; ocular pharmacokinetics; transcorneal permeation; quality by Design (QbD); nano-pharmaceuticals; pharmaceutical industry; polyamidoamine dendrimers; erlotinib; non-small-cell lung cancer; n/a
• Dostęp online: DOAB: download the publication; DOAB: description of the publication

Streszczenie

This reprint entitled "Nanomedicine Based Drug Delivery Systems: Recent Developments and Future Prospects" contains 14 articles in total. This includes one editorial, ten research articles, and three review articles. All articles are associated with nanomedicine-based drug delivery systems for the solubility, bioavailability, and therapeutic enhancement of active drug molecules. In recent years, there has been a tremendous amount of research on nanomedicine-based drug delivery systems. This reprint has brought together prominent scientists who have explored a diverse range of applications of nanomedicine-based drug delivery systems. I believe that further clinical and toxicological studies on both animal and human models are still required to explore the complete potential and commercial exploitation of nanomedicine-based drug delivery systems. The diverse and critical perspectives within this reprint provide sufficient information on the development, characterization, and evaluation of nanomedicine-based drug delivery systems.

Opis fizyczny

1 electronic resource (242 p.)

ISBN

books978-3-0365-7760-9
9783036577616
9783036577609

Ograniczenie dostępu

Open Access